Peer-reviewedCC BY-NC-ND 4.0Journal of the National Cancer Center
Reprogramming cancer at the tipping point
- 1Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece
- 2Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, USA
- 3First University Department of Respiratory Medicine, 'Sotiria' Chest Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Related
- Quantifying Academic Risk Factors for Student Depression Using WHO Frameworks: Odds Ratios, SHAP Explainability, and Tipping Point Analysis
- Targeting Metabolic Reprogramming in Cancer: Past, Present, and Future
- HER3 mediates metabolic reprogramming in metastatic colorectal and pancreatic cancer
- Engineering clinically actionable nanomedicine for cancer immunometabolic ecosystem reprogramming
- PTTG1 drives intestinal-type gastric cancer progression via G2/M checkpoint-mediated cell-cycle reprogramming
BibTeX
@article{adamopoulos2026reprogramming,
title = {{Reprogramming cancer at the tipping point}},
author = {Christos Adamopoulos and Kostas A. Papavassiliou and Athanasios G. Papavassiliou},
journal = {Journal of the National Cancer Center},
year = {2026},
month = aug,
doi = {10.1016/j.jncc.2026.08.005},
url = {https://doi.org/10.1016/j.jncc.2026.08.005},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Reprogramming cancer at the tipping point
AU - Christos Adamopoulos
AU - Kostas A. Papavassiliou
AU - Athanasios G. Papavassiliou
PY - 2026
DA - 2026/08/24
JO - Journal of the National Cancer Center
DO - 10.1016/j.jncc.2026.08.005
UR - https://doi.org/10.1016/j.jncc.2026.08.005
SN - 2096-8663
SN - 2667-0054
ER -